Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Cancer Investigation|January 1, 1988
Treatment of "limited" stage III non-small cell carcinoma of the lungS Frytak, R T Eagan, K Sawamura, et al.
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer Treatment Reports|July 1, 1976
ICRF-159 versus polychemotherapy in non-small cell lung cancerR T Eagan, D T Carr, D T Coles, et al.
American Journal of Clinical Oncology|November 5, 1997
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trialS V Rajkumar, S Frytak, J Rubin, et al.
Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.
Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.
Chest|August 1, 1990
Life-threatening bleomycin pulmonary toxicity with ultimate reversibilityL C Hartmann, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
Cancer Treatment Reports|March 1, 1978
Phase II study of metronidazole therapy for advanced colorectal carcinomaS Frytak, C G Moertel, D S Childs, et al.
Cancer Treatment Reports|March 1, 1986
Phase II trial of diaziquone in malignant mesotheliomaR T Eagan, S Frytak, R L Richardson, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Cancer Investigation|January 1, 1988
Treatment of "limited" stage III non-small cell carcinoma of the lungS Frytak, R T Eagan, K Sawamura, et al.
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer Treatment Reports|July 1, 1976
ICRF-159 versus polychemotherapy in non-small cell lung cancerR T Eagan, D T Carr, D T Coles, et al.
American Journal of Clinical Oncology|November 5, 1997
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trialS V Rajkumar, S Frytak, J Rubin, et al.
Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.
Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.
Chest|August 1, 1990
Life-threatening bleomycin pulmonary toxicity with ultimate reversibilityL C Hartmann, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1984
Phase I study of diaziquoneS Frytak, R T Eagan, M M Ames, et al.
Cancer Treatment Reports|March 1, 1978
Phase II study of metronidazole therapy for advanced colorectal carcinomaS Frytak, C G Moertel, D S Childs, et al.
Cancer Treatment Reports|March 1, 1986
Phase II trial of diaziquone in malignant mesotheliomaR T Eagan, S Frytak, R L Richardson, et al.
Pageof 11